Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5414 Target Snapshot

Beta-2 adrenergic receptor · SINGLE PROTEIN · Cavia porcellus

759Compounds
182Assays
26Approved Drugs
557.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q8K4Z4. Use UniProt Q8K4Z4 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q8K4Z4 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Beta-2 adrenergic receptor as ChEMBL target CHEMBL5414, mapped to UniProt Q8K4Z4. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Beta-2 adrenergic receptor
SINGLE PROTEIN · Cavia porcellus
As of 2026-09-14
ChEMBL target ID
CHEMBL5414
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q8K4Z4
Beta-2 adrenergic receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Beta-2 adrenergic receptor is the right protein anchor across sources, using UniProt Q8K4Z4 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelBeta-2 adrenergic receptor
UniProt AccessionQ8K4Z4
Component TypeProtein
Sequence Length418 aa

Beta-2 adrenergic receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Beta-2 adrenergic receptor, mapped to UniProt Q8K4Z4. Sequence length is 418 aa.

Mapped IDQ8K4Z4
Review nameBeta-2 adrenergic receptor
OrganismCavia porcellus
Clinical Profile

Clinical Phase Distribution

26
Approved
11
Phase II
Assay Mix

Activity Type Distribution

IC5087.0
KI14.0
EC50152.0
KD304.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5557828 10.9 IC50 0.01259 Preclinical
CHEMBL5505816 10.6 IC50 0.02512 Preclinical
CHEMBL1682213 10.3 EC50 0.05 Preclinical
CHEMBL1940832 10.3 EC50 0.05012 Clinical
CHEMBL5208201 10.3 IC50 0.05012 Preclinical
CHEMBL6067687 10.3 IC50 0.05012 Preclinical
CHEMBL304344 10.2 Kd 0.0631 Preclinical
CHEMBL1682210 10.15 EC50 0.07 Preclinical
CHEMBL552398 10.14 EC50 0.072 Preclinical
CHEMBL5172865 10.1 IC50 0.07943 Preclinical
Distribution

pChEMBL Value Distribution

39
5.0
52
5.5
46
6.0
62
6.5
50
7.0
65
7.5
38
8.0
36
8.5
28
9.0
29
9.5
pChEMBL
Approved Drugs

Approved Drugs

INDACATEROL
CHEMBL1095777
Approved 2009
ARFORMOTEROL
CHEMBL1363
Approved 2006
ARFORMOTEROL TARTRATE
CHEMBL1951071
Approved 2006
DARIFENACIN
CHEMBL1346
Approved 2004
FORMOTEROL
CHEMBL1256786
Approved 2001
SALMETEROL
CHEMBL1263
Approved 1994
BETAXOLOL
CHEMBL423
Approved 1985
LABETALOL
CHEMBL429
Approved 1984
ALBUTEROL
CHEMBL714
Approved 1981
TIMOLOL
CHEMBL499
Approved 1978
METOPROLOL
CHEMBL13
Approved 1978
PROPRANOLOL
CHEMBL27
Approved 1967
EPINEPHRINE
CHEMBL679
Approved 1965
ISOPROTERENOL
CHEMBL434
Approved 1956
NOREPINEPHRINE
CHEMBL1437
Approved 1950
Assay Landscape

Assay Landscape

182
Total Assays
251
Tested Compounds
2
Assay Types
Binding — 104 assays, 251 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 89 194 6.6
tissue-based format 13 53 6.6
cell membrane format 2 4 7.1
Functional — 78 assays, 186 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 45 140 8.0
assay format 33 46 7.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine